In agreement, administration of anti-IL-18 antibodies prior to systemic Candida infection depleted IFN-γ responses and enhanced fungal disease (Stuyt et al., 2002), whereas increasing IL-18 enhanced IFN-γ and Th1 responses which ultimately promoted protection (Stuyt et al., 2004). Here, IL18 is linked to candidiasis.